药用玻璃包装市场机会、成长动力、产业趋势分析及2025-2034年预测

全球医药玻璃包装市场价值 2024 年将达到 219 亿美元，预计 2025 年至 2034 年的复合年增长率将达到 10.1%。市场成长的激增是由全球对药品的需求不断增长，加上确保药品安全和完整性的严格监管要求所推动的。随着製药业寻求高度可靠和无污染的包装解决方案，玻璃因其优异的耐化学性、耐用性和非反应性而继续受到关注。

生物製剂、疫苗和注射的日益普及进一步扩大了对专用玻璃包装的需求，特别是 1 型硼硅酸盐玻璃，它可以提供无与伦比的防化学反应和热波动保护。政府和监管机构正在加强遵守严格的包装标准，使玻璃成为关键药物配方的首选。个人化医疗、细胞和基因疗法的转变也推动製造商开发创新和永续的玻璃包装解决方案，以满足高价值药物和复杂生物製剂的需求。

随着全球对永续性的关注度不断提高，製药公司正在投资环保和可回收的包装替代品。轻质玻璃解决方案正在获得发展动力，因为它们有助于降低运输成本，同时保持药物稳定性和保护的高标准。新兴市场，尤其是亚太地区的新兴市场，正在经历药品生产的强劲成长，导致仿製药和品牌药对玻璃包装的采用率更高。生物相似药的兴起和严格的序列化法规进一步要求玻璃包装，以确保产品的可追溯性和安全性。

药用玻璃包装市场主要按材料类型分类，其中 1 型玻璃占据主导地位。 2024 年，这一类别的市场规模将达到 90 亿美元，这得益于生物製剂、疫苗和注射药物储存对硼硅酸盐玻璃的需求不断增长。 1 型玻璃因其优异的耐化学性、防止药物污染和降解而受到广泛青睐。强制要求在敏感配方中使用硼硅酸盐玻璃的严格监管准则的实施继续加速了其市场需求。

根据产品类型，市场包括小瓶、瓶子、注射器、安瓿瓶和其他包装形式。瓶装饮料是该领域的佼佼者，预计到 2024 年将创造 63 亿美元的市场价值，这主要是由于慢性病的发病率不断上升，从而推动了对糖浆等液体製剂的需求。许多此类製剂都需要琥珀色玻璃瓶来保护其免受紫外线照射，这进一步增加了对专用药用玻璃包装的需求。该行业正在经历向轻质玻璃瓶的转变，这种玻璃瓶在保持可回收性和法规遵从性的同时，也提供了物流成本效率。

北美仍然是药用玻璃包装市场的主导力量，光是美国在 2024 年的市场规模就将达到 68 亿美元。美国高度发展的製药业，加上生物製剂和疫苗产量和出口量的不断增加，继续推动对高品质玻璃包装的巨大需求。由于製药商优先考虑安全性、永续性和法规遵循性，美国将继续保持其作为全球市场主要贡献者的地位。

目录

第一章：方法论与范围

第二章：执行摘要

第三章：行业洞察

• 产业生态系统分析
• 产业衝击力
  • 成长动力
    • 药品安全监理严格
    • 人口老化与慢性病
    • 全球医药需求不断成长
    • 玻璃包装技术进步
    • 偏好即用型包装
  • 产业陷阱与挑战
    • 脆弱性和破损风险
    • 玻璃包装成本高
• 成长潜力分析
• 监管格局
• 技术格局
• 未来市场趋势
• 差距分析
• 波特的分析
• PESTEL 分析

第四章：竞争格局

• 介绍
• 公司市占率分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 策略仪表板

第五章：市场估计与预测：按材料，2021 年至 2034 年

• 主要趋势
• l型
• 类型 II
• 类型 III

第六章：市场估计与预测：按产品，2021 年至 2034 年

• 主要趋势
• 西林瓶
• 瓶子
• 墨水匣和注射器
• 安瓿
• 其他的

第七章：市场估计与预测：依药物类型，2021 年至 2034 年

• 主要趋势
• 注射药物
• 口服药物
• 外用药物
• 眼科药物

第 8 章：市场估计与预测：按应用，2021 年至 2034 年

• 主要趋势
• 通用的
• 品牌
• 生物

第九章：市场估计与预测：按地区，2021 年至 2034 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东和非洲
  • 沙乌地阿拉伯
  • 南非
  • 阿联酋

第十章：公司简介

• Arab Pharmaceutical Glass
• Ardagh Group
• Beatson Clark
• Corning
• DWK Life Sciences
• Gerresheimer
• Glassco
• Nipro
• PGP Glass
• Schott
• SGD
• Shandong Medicinal Glass
• Stevanato Group
• Stoelzle Oberglas
• United Glass Company
• West Pharmaceutical Services

The Global Pharmaceutical Glass Packaging Market, valued at USD 21.9 billion in 2024, is projected to expand at a CAGR of 10.1% from 2025 to 2034. The surge in market growth is driven by the increasing demand for pharmaceuticals worldwide, coupled with stringent regulatory requirements ensuring drug safety and integrity. As the pharmaceutical industry seeks highly reliable and contamination-free packaging solutions, glass continues to gain traction due to its superior chemical resistance, durability, and non-reactive properties.

The rising adoption of biologics, vaccines, and injectables is further amplifying the need for specialized glass packaging, particularly Type 1 borosilicate glass, which offers unparalleled protection against chemical interactions and thermal fluctuations. Governments and regulatory bodies are reinforcing compliance with strict packaging standards, making glass the preferred choice for critical drug formulations. The shift toward personalized medicine and cell and gene therapies is also driving manufacturers to develop innovative and sustainable glass packaging solutions that cater to high-value drugs and complex biologics.

With an increasing global focus on sustainability, pharmaceutical companies are investing in eco-friendly and recyclable packaging alternatives. Lightweight glass solutions are gaining momentum as they help reduce transportation costs while maintaining high standards for drug stability and protection. Emerging markets, particularly in Asia-Pacific, are experiencing robust growth in pharmaceutical production, leading to higher adoption rates for glass packaging in both generic and branded drugs. The rise of biosimilars and stringent serialization regulations further necessitate the demand for glass packaging, ensuring product traceability and safety.

The pharmaceutical glass packaging market is primarily categorized by material type, with Type 1 glass dominating the segment. In 2024, this category accounted for USD 9 billion, fueled by the increasing demand for borosilicate glass in the storage of biologics, vaccines, and injectable drugs. Type 1 glass is widely preferred due to its superior chemical resistance, preventing drug contamination and degradation. The implementation of strict regulatory guidelines that mandate the use of borosilicate glass for sensitive formulations continues to accelerate its market demand.

Based on product type, the market includes vials, bottles, syringes, ampoules, and other packaging formats. Bottles lead the segment, generating USD 6.3 billion in 2024, primarily due to the rising prevalence of chronic diseases that drive demand for liquid formulations such as syrups. Many of these formulations require amber-colored glass bottles to protect them from UV exposure, further boosting the demand for specialized pharmaceutical glass packaging. The industry is witnessing a shift toward lightweight glass bottles, which provide cost efficiency in logistics while maintaining recyclability and regulatory compliance.

North America remains a dominant force in the pharmaceutical glass packaging market, with the United States alone generating USD 6.8 billion in 2024. The country's highly advanced pharmaceutical sector, along with increasing production and exports of biologics and vaccines, continues to drive significant demand for high-quality glass packaging. With pharmaceutical manufacturers prioritizing safety, sustainability, and regulatory compliance, the U.S. is set to retain its position as a key contributor to the global market.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Stringent regulations on drug safety
    • 3.2.1.2 Aging population and chronic disease
    • 3.2.1.3 Rising global pharmaceutical demand
    • 3.2.1.4 Technological advancement in glass packaging
    • 3.2.1.5 Preference for ready to use packaging
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Fragility and breakage risks
    • 3.2.2.2 High cost of glass packaging
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technology landscape
• 3.6 Future market trends
• 3.7 Gap analysis
• 3.8 Porter’s analysis
• 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Material, 2021 – 2034 (USD Billion & Kilo Tons)

• 5.1 Key trends
• 5.2 Type l
• 5.3 Type ll
• 5.4 Type lll

Chapter 6 Market Estimates and Forecast, By Product, 2021 – 2034 (USD Billion & Kilo Tons)

• 6.1 Key trends
• 6.2 Vials
• 6.3 Bottles
• 6.4 Cartridges & syringes
• 6.5 Ampoules
• 6.6 Others

Chapter 7 Market Estimates and Forecast, By Drug Type, 2021 – 2034 (USD Billion & Kilo Tons)

• 7.1 Key trends
• 7.2 Injectable drugs
• 7.3 Oral drugs
• 7.4 Topical drugs
• 7.5 Ophthalmic drugs

Chapter 8 Market Estimates and Forecast, By Application, 2021 – 2034 (USD Billion & Kilo Tons)

• 8.1 Key trends
• 8.2 Generic
• 8.3 Branded
• 8.4 Biologic

Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2034 (USD Billion & Kilo Tons)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 India
  • 9.4.3 Japan
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 Middle East and Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 South Africa
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 Arab Pharmaceutical Glass
• 10.2 Ardagh Group
• 10.3 Beatson Clark
• 10.4 Corning
• 10.5 DWK Life Sciences
• 10.6 Gerresheimer
• 10.7 Glassco
• 10.8 Nipro
• 10.9 PGP Glass
• 10.10 Schott
• 10.11 SGD
• 10.12 Shandong Medicinal Glass
• 10.13 Stevanato Group
• 10.14 Stoelzle Oberglas
• 10.15 United Glass Company
• 10.16 West Pharmaceutical Services